| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arrhythmias, Cardiac | 29 | 2025 | 479 | 6.020 |
Why?
|
| Tachycardia, Ventricular | 15 | 2024 | 211 | 4.840 |
Why?
|
| Long QT Syndrome | 8 | 2023 | 85 | 3.000 |
Why?
|
| Electrocardiography | 28 | 2024 | 996 | 2.420 |
Why?
|
| Defibrillators, Implantable | 8 | 2023 | 204 | 2.160 |
Why?
|
| Anti-Arrhythmia Agents | 19 | 2024 | 217 | 1.940 |
Why?
|
| Tachycardia, Supraventricular | 9 | 2024 | 106 | 1.890 |
Why?
|
| Heart Arrest | 4 | 2022 | 373 | 1.500 |
Why?
|
| Wolff-Parkinson-White Syndrome | 5 | 2024 | 73 | 1.330 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 2 | 2023 | 40 | 1.280 |
Why?
|
| Atrial Fibrillation | 6 | 2024 | 738 | 1.280 |
Why?
|
| Heart Defects, Congenital | 15 | 2024 | 1867 | 1.260 |
Why?
|
| Death, Sudden, Cardiac | 8 | 2022 | 274 | 1.230 |
Why?
|
| Exercise Test | 4 | 2019 | 256 | 1.220 |
Why?
|
| Cardiomyopathies | 5 | 2022 | 509 | 1.210 |
Why?
|
| Child | 58 | 2025 | 25758 | 1.020 |
Why?
|
| Vitamin B Complex | 2 | 2023 | 42 | 0.990 |
Why?
|
| Cardiomyopathy, Hypertrophic | 7 | 2021 | 158 | 0.990 |
Why?
|
| Echocardiography | 9 | 2021 | 1126 | 0.950 |
Why?
|
| Heart Rate | 8 | 2024 | 587 | 0.940 |
Why?
|
| Adolescent | 45 | 2025 | 20530 | 0.910 |
Why?
|
| Sotalol | 5 | 2023 | 32 | 0.900 |
Why?
|
| Pacemaker, Artificial | 6 | 2025 | 188 | 0.870 |
Why?
|
| Child, Preschool | 34 | 2025 | 14719 | 0.790 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2025 | 215 | 0.760 |
Why?
|
| Catheter Ablation | 8 | 2022 | 257 | 0.730 |
Why?
|
| Infant | 31 | 2025 | 13037 | 0.730 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 9 | 0.710 |
Why?
|
| Retrospective Studies | 41 | 2025 | 17367 | 0.710 |
Why?
|
| Humans | 94 | 2025 | 132093 | 0.700 |
Why?
|
| Heart Conduction System | 4 | 2017 | 156 | 0.700 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.690 |
Why?
|
| Male | 61 | 2025 | 64951 | 0.650 |
Why?
|
| Cardiology | 7 | 2021 | 497 | 0.650 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 105 | 0.630 |
Why?
|
| Atrioventricular Block | 5 | 2025 | 46 | 0.630 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 34 | 0.620 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 87 | 0.610 |
Why?
|
| Female | 59 | 2025 | 70715 | 0.600 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 73 | 0.600 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 856 | 0.590 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 403 | 0.580 |
Why?
|
| Seizures | 2 | 2024 | 895 | 0.570 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 5 | 2024 | 65 | 0.560 |
Why?
|
| Mutation | 7 | 2021 | 6247 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3358 | 0.540 |
Why?
|
| Heart Failure | 5 | 2023 | 2398 | 0.530 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 604 | 0.510 |
Why?
|
| Phenotype | 6 | 2022 | 4539 | 0.490 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2022 | 25 | 0.470 |
Why?
|
| Sick Sinus Syndrome | 1 | 2015 | 15 | 0.470 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2016 | 67 | 0.460 |
Why?
|
| Syncope | 1 | 2015 | 51 | 0.460 |
Why?
|
| Follow-Up Studies | 13 | 2019 | 5407 | 0.460 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 316 | 0.450 |
Why?
|
| Electric Countershock | 4 | 2021 | 73 | 0.430 |
Why?
|
| Radiation Dosage | 2 | 2013 | 146 | 0.430 |
Why?
|
| Treatment Outcome | 21 | 2024 | 13015 | 0.410 |
Why?
|
| Flecainide | 3 | 2021 | 21 | 0.410 |
Why?
|
| Myocytes, Cardiac | 4 | 2024 | 651 | 0.410 |
Why?
|
| Propranolol | 3 | 2022 | 112 | 0.400 |
Why?
|
| Sudden Infant Death | 1 | 2013 | 36 | 0.400 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 53 | 0.400 |
Why?
|
| Young Adult | 17 | 2025 | 9938 | 0.390 |
Why?
|
| Myocarditis | 1 | 2013 | 131 | 0.380 |
Why?
|
| Heart | 3 | 2015 | 698 | 0.380 |
Why?
|
| Genetic Testing | 4 | 2025 | 1098 | 0.370 |
Why?
|
| Body Surface Potential Mapping | 2 | 2012 | 12 | 0.370 |
Why?
|
| Fluoroscopy | 2 | 2013 | 100 | 0.360 |
Why?
|
| Cardiac Pacing, Artificial | 4 | 2020 | 126 | 0.350 |
Why?
|
| Pedigree | 4 | 2024 | 1724 | 0.350 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 548 | 0.340 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2020 | 29 | 0.340 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 4 | 2024 | 246 | 0.340 |
Why?
|
| Diagnosis, Differential | 3 | 2023 | 1966 | 0.340 |
Why?
|
| Hospitalization | 4 | 2022 | 1897 | 0.330 |
Why?
|
| Endosonography | 1 | 2010 | 82 | 0.330 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 105 | 0.330 |
Why?
|
| Patient Care Management | 2 | 2020 | 66 | 0.330 |
Why?
|
| Risk Factors | 14 | 2025 | 10936 | 0.330 |
Why?
|
| Incidence | 10 | 2024 | 3370 | 0.310 |
Why?
|
| Infant, Newborn | 15 | 2021 | 8539 | 0.310 |
Why?
|
| Inpatients | 1 | 2013 | 553 | 0.300 |
Why?
|
| United States | 18 | 2025 | 11652 | 0.300 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2008 | 7 | 0.290 |
Why?
|
| Predictive Value of Tests | 7 | 2020 | 2312 | 0.280 |
Why?
|
| Electroencephalography | 3 | 2025 | 908 | 0.280 |
Why?
|
| Exome | 4 | 2022 | 1087 | 0.270 |
Why?
|
| Rheumatic Fever | 1 | 2007 | 18 | 0.270 |
Why?
|
| Genetic Variation | 4 | 2025 | 1580 | 0.260 |
Why?
|
| Epilepsy | 2 | 2025 | 891 | 0.260 |
Why?
|
| American Heart Association | 5 | 2020 | 309 | 0.250 |
Why?
|
| DNA | 2 | 2025 | 1478 | 0.250 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2020 | 134 | 0.240 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2017 | 91 | 0.240 |
Why?
|
| Prospective Studies | 8 | 2025 | 6556 | 0.240 |
Why?
|
| Texas | 7 | 2019 | 3632 | 0.240 |
Why?
|
| Survival Rate | 6 | 2021 | 2192 | 0.240 |
Why?
|
| Heart Atria | 3 | 2024 | 336 | 0.240 |
Why?
|
| N-Terminal Acetyltransferase A | 1 | 2025 | 10 | 0.230 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2025 | 11 | 0.230 |
Why?
|
| Amiodarone | 2 | 2024 | 44 | 0.230 |
Why?
|
| Time Factors | 11 | 2024 | 6448 | 0.230 |
Why?
|
| Gene Deletion | 3 | 2018 | 794 | 0.230 |
Why?
|
| Cardiac Electrophysiology | 2 | 2016 | 15 | 0.230 |
Why?
|
| Mass Screening | 3 | 2017 | 830 | 0.230 |
Why?
|
| Tetracaine | 1 | 2024 | 12 | 0.220 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2024 | 64 | 0.220 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 258 | 0.210 |
Why?
|
| Adult | 17 | 2025 | 31560 | 0.210 |
Why?
|
| Medicine | 2 | 2022 | 106 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2021 | 3727 | 0.200 |
Why?
|
| Hospital Mortality | 3 | 2022 | 1078 | 0.200 |
Why?
|
| Heart Block | 1 | 2022 | 38 | 0.190 |
Why?
|
| Atrial Flutter | 1 | 2022 | 35 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 1802 | 0.190 |
Why?
|
| Statistics, Nonparametric | 3 | 2016 | 438 | 0.190 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2022 | 14 | 0.190 |
Why?
|
| Vitamins | 1 | 2022 | 112 | 0.190 |
Why?
|
| Verapamil | 1 | 2022 | 52 | 0.190 |
Why?
|
| Siblings | 1 | 2023 | 202 | 0.190 |
Why?
|
| Administration, Intravenous | 2 | 2023 | 162 | 0.190 |
Why?
|
| Isoproterenol | 1 | 2022 | 97 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 217 | 0.180 |
Why?
|
| Folic Acid | 1 | 2024 | 289 | 0.180 |
Why?
|
| Neuroimaging | 1 | 2025 | 375 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 137 | 0.180 |
Why?
|
| Magnesium | 1 | 2022 | 114 | 0.180 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2021 | 13 | 0.180 |
Why?
|
| Education, Distance | 1 | 2022 | 67 | 0.180 |
Why?
|
| Heart-Assist Devices | 2 | 2025 | 1085 | 0.180 |
Why?
|
| Canada | 4 | 2019 | 337 | 0.180 |
Why?
|
| Acute Disease | 3 | 2023 | 1161 | 0.180 |
Why?
|
| Genotype | 3 | 2023 | 2703 | 0.180 |
Why?
|
| Adenosine | 1 | 2022 | 135 | 0.170 |
Why?
|
| Heart Ventricles | 4 | 2024 | 785 | 0.170 |
Why?
|
| Facies | 1 | 2021 | 156 | 0.170 |
Why?
|
| Postoperative Complications | 5 | 2020 | 3129 | 0.160 |
Why?
|
| Consensus | 3 | 2020 | 656 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2016 | 289 | 0.160 |
Why?
|
| Dietary Supplements | 1 | 2023 | 439 | 0.160 |
Why?
|
| Prenatal Care | 1 | 2022 | 359 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2021 | 219 | 0.150 |
Why?
|
| Primary Prevention | 1 | 2021 | 179 | 0.150 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 44 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 553 | 0.150 |
Why?
|
| Aftercare | 1 | 2020 | 155 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2013 | 1175 | 0.150 |
Why?
|
| Myopathies, Nemaline | 1 | 2018 | 7 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 175 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2022 | 459 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2022 | 336 | 0.150 |
Why?
|
| Ebstein Anomaly | 1 | 2018 | 29 | 0.140 |
Why?
|
| Cohort Studies | 6 | 2020 | 5169 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2023 | 875 | 0.140 |
Why?
|
| Quality of Life | 2 | 2022 | 2159 | 0.140 |
Why?
|
| Cognition | 1 | 2023 | 811 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 163 | 0.140 |
Why?
|
| Desmoplakins | 1 | 2017 | 12 | 0.140 |
Why?
|
| Keratosis | 1 | 2017 | 17 | 0.140 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 19 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2022 | 609 | 0.140 |
Why?
|
| Catecholamines | 1 | 2017 | 52 | 0.140 |
Why?
|
| Age Factors | 5 | 2019 | 2922 | 0.130 |
Why?
|
| Heterotaxy Syndrome | 1 | 2017 | 63 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 45 | 0.130 |
Why?
|
| Algorithms | 3 | 2020 | 1724 | 0.130 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 663 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 375 | 0.130 |
Why?
|
| Azithromycin | 1 | 2016 | 43 | 0.130 |
Why?
|
| Troponin T | 1 | 2018 | 295 | 0.130 |
Why?
|
| Syndactyly | 1 | 2016 | 24 | 0.120 |
Why?
|
| Athletes | 1 | 2017 | 73 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 52 | 0.120 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 88 | 0.120 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 16 | 0.120 |
Why?
|
| Tilt-Table Test | 1 | 2015 | 9 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 36 | 0.120 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 780 | 0.120 |
Why?
|
| Pulmonary Valve | 1 | 2016 | 98 | 0.120 |
Why?
|
| Amino Acids | 1 | 2018 | 626 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2016 | 93 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2013 | 1072 | 0.110 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 245 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 183 | 0.110 |
Why?
|
| Weightlessness Simulation | 1 | 2014 | 21 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1670 | 0.110 |
Why?
|
| Digoxin | 1 | 2014 | 39 | 0.110 |
Why?
|
| Tachycardia, Reciprocating | 1 | 2014 | 3 | 0.110 |
Why?
|
| Sports | 2 | 2013 | 66 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 153 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 13 | 0.110 |
Why?
|
| Pediatrics | 2 | 2014 | 1208 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1082 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 69 | 0.110 |
Why?
|
| Cryosurgery | 1 | 2014 | 49 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 159 | 0.110 |
Why?
|
| Stroke Volume | 2 | 2013 | 536 | 0.100 |
Why?
|
| Sympathectomy | 1 | 2013 | 8 | 0.100 |
Why?
|
| Anesthetics, Dissociative | 1 | 2013 | 18 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 65 | 0.100 |
Why?
|
| Middle Aged | 8 | 2025 | 28981 | 0.100 |
Why?
|
| Electrophysiology | 1 | 2013 | 268 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 65 | 0.100 |
Why?
|
| Australia | 1 | 2013 | 185 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 88 | 0.100 |
Why?
|
| Recurrence | 2 | 2014 | 1452 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 463 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2013 | 277 | 0.100 |
Why?
|
| Calcium | 2 | 2014 | 1079 | 0.100 |
Why?
|
| Prognosis | 3 | 2023 | 5013 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2013 | 47 | 0.100 |
Why?
|
| Autistic Disorder | 1 | 2016 | 387 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2016 | 550 | 0.090 |
Why?
|
| Databases as Topic | 2 | 2014 | 76 | 0.090 |
Why?
|
| Shock, Cardiogenic | 1 | 2014 | 213 | 0.090 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2012 | 33 | 0.090 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2011 | 3 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2016 | 323 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 462 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 79 | 0.090 |
Why?
|
| Age Distribution | 2 | 2016 | 433 | 0.090 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 15 | 0.090 |
Why?
|
| Myxoma | 1 | 2011 | 29 | 0.090 |
Why?
|
| Fibroma | 1 | 2011 | 31 | 0.090 |
Why?
|
| Ventricular Function, Right | 1 | 2012 | 119 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2016 | 778 | 0.090 |
Why?
|
| Pericardium | 1 | 2012 | 91 | 0.090 |
Why?
|
| Sinus of Valsalva | 1 | 2011 | 35 | 0.090 |
Why?
|
| Mice | 7 | 2024 | 18535 | 0.080 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2010 | 8 | 0.080 |
Why?
|
| Risk Adjustment | 2 | 2020 | 55 | 0.080 |
Why?
|
| Patient Selection | 3 | 2020 | 730 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2013 | 473 | 0.080 |
Why?
|
| Pregnancy | 1 | 2022 | 7548 | 0.080 |
Why?
|
| Atrial Appendage | 1 | 2010 | 74 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1295 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2012 | 271 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1163 | 0.080 |
Why?
|
| Ketamine | 1 | 2013 | 226 | 0.080 |
Why?
|
| Syndrome | 2 | 2025 | 1173 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 309 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2011 | 462 | 0.070 |
Why?
|
| Chorea | 1 | 2007 | 39 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2014 | 659 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 1440 | 0.060 |
Why?
|
| Animals | 7 | 2024 | 34912 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2007 | 144 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2024 | 937 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2087 | 0.060 |
Why?
|
| Seasons | 1 | 2007 | 328 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 826 | 0.060 |
Why?
|
| Homozygote | 2 | 2018 | 548 | 0.060 |
Why?
|
| Age of Onset | 2 | 2017 | 626 | 0.060 |
Why?
|
| Amidohydrolases | 1 | 2025 | 23 | 0.060 |
Why?
|
| United Kingdom | 1 | 2025 | 233 | 0.060 |
Why?
|
| Exons | 2 | 2018 | 803 | 0.060 |
Why?
|
| Device Removal | 2 | 2019 | 225 | 0.050 |
Why?
|
| Epilepsy, Generalized | 1 | 2024 | 65 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 49 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2024 | 250 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 590 | 0.050 |
Why?
|
| Vitamin K | 1 | 2022 | 38 | 0.050 |
Why?
|
| Vitamin A | 1 | 2022 | 56 | 0.050 |
Why?
|
| Tachycardia | 1 | 2022 | 68 | 0.050 |
Why?
|
| California | 2 | 2013 | 140 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1500 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 451 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 421 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1460 | 0.040 |
Why?
|
| Base Sequence | 2 | 2016 | 2897 | 0.040 |
Why?
|
| Parents | 2 | 2022 | 1080 | 0.040 |
Why?
|
| Cardiac Catheterization | 2 | 2017 | 671 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 3044 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 64 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4688 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 97 | 0.040 |
Why?
|
| Czech Republic | 1 | 2019 | 12 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 553 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 282 | 0.040 |
Why?
|
| Comorbidity | 2 | 2016 | 1610 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 21456 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 437 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 545 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2025 | 1093 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 3984 | 0.030 |
Why?
|
| Antigens | 1 | 2017 | 149 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2017 | 62 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 92 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2012 | 511 | 0.030 |
Why?
|
| Telemetry | 1 | 2016 | 28 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 595 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 569 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2014 | 767 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 511 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 30 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2016 | 139 | 0.030 |
Why?
|
| Penicillins | 1 | 2016 | 155 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 670 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 80 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 94 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 95 | 0.030 |
Why?
|
| Sodium Channels | 1 | 2015 | 104 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 750 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 165 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 618 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 126 | 0.030 |
Why?
|
| Europe | 1 | 2016 | 373 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 688 | 0.030 |
Why?
|
| Hindlimb Suspension | 1 | 2014 | 12 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 341 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 1050 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 500 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 1652 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 154 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 168 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 144 | 0.030 |
Why?
|
| Boston | 1 | 2013 | 122 | 0.030 |
Why?
|
| Punctures | 1 | 2013 | 65 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3854 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 132 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 568 | 0.020 |
Why?
|
| Brain | 1 | 2025 | 3198 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1571 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 292 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1096 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 333 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1451 | 0.020 |
Why?
|
| Patient Safety | 1 | 2017 | 438 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1038 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 881 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 172 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1230 | 0.020 |
Why?
|
| Self Concept | 1 | 2012 | 164 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1993 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 89 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 154 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2012 | 177 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 142 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2144 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1034 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1684 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2011 | 105 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3771 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1613 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1352 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 588 | 0.020 |
Why?
|
| Anesthesia | 1 | 2013 | 209 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 59 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 2487 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 330 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 610 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 3023 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 995 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 1331 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1255 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3086 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3606 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 341 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 850 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 348 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1836 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3866 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 463 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4757 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 7125 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3753 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 3403 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4717 | 0.010 |
Why?
|